488 results
8-K
EX-99
PFE
Pfizer Inc.
1 May 24
Pfizer Reports First-Quarter 2024 Results
8:11am
health outcomes in medically underrepresented communities across the U.S. by enhancing awareness of and access to cancer screenings, clinical trial … affecting, among other things, pharmaceutical product pricing, intellectual property, reimbursement or access or restrictions on U.S. direct-to-consumer
PX14A6G
Tara Health Foundation
16 Apr 24
Letter to shareholders
10:19am
women, ensure equal opportunities for leadership and access to reproductive health.” Such a report should identify and explain trends of incongruent … support this proposal because it is apparent that many recipients of the Company’s political contributions are working actively to undermine access
S-3ASR
Pfizer Investment Enterprises PTE Ltd
23 Feb 24
Automatic shelf registration
4:34pm
with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world.
We
8-K
EX-99
4hw aspfhy8ih
30 Jan 24
Pfizer Reports Full-Year 2023 Results and Reaffirms Full-Year 2024 Financial Guidance
8:04am
8-K
EX-99.1
ve1j3le2w1ybmm3dsz
10 Jan 24
Pfizer Recommends Shareholders Reject the Below-Market Mini-Tender Offer by TRC Capital Investment Corporation
4:38pm
8-K/A
EX-99.1
sn38of9r9xu g54sz
14 Dec 23
Pfizer Completes Acquisition of Seagen
5:04pm
8-K
EX-99.1
pdykg d204x8wv
14 Dec 23
Pfizer Completes Acquisition of Seagen
7:51am
8-K
EX-99.1
j1rfugl4kmf 39x34khx
13 Dec 23
Full-Year 2024 Revenue Guidance(1) Range of $58.5 to $61.5 Billion Includes Expected Contribution from Seagen Acquisition
7:44am
8-K
EX-99.1
0j129dzj7mz0imw30e2
12 Dec 23
Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen
4:35pm
8-K
EX-99
fz28zu695o
31 Oct 23
Pfizer Reports Third-Quarter 2023 Results
8:04am
8-K
EX-99
k7fxpp67hp4j ze
13 Oct 23
Pfizer Amends U.S. Government Paxlovid Supply Agreement and Updates Full-Year 2023 Guidance
5:30pm
8-K
7m4w76unb1tbbz6
13 Oct 23
Pfizer Amends U.S. Government Paxlovid Supply Agreement and Updates Full-Year 2023 Guidance
5:30pm
8-K
EX-99
z1osi498ny
1 Aug 23
Pfizer Reports Second-Quarter 2023 Results
8:09am
8-K
EX-1.1
venym0
19 May 23
Other Events
4:26pm
424B5
ahu spxcx01u48
18 May 23
Prospectus supplement for primary offering
4:37pm